EFFECT OF LOW-PURITY AND INTERMEDIATE-PURITY CLOTTING FASTER THERAPY ON PROGRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN CONGENITALCLOTTING DISORDERS

GJERSET GF PIKE MC MOSLEY JW HASSETT J FLETCHER MA DONEGAN E PARKER JW COUNTS RB ZHOU Y KASPER CK OPERSKALSKI EA BUCKLEY J GAIENNIE J HARRIS M LEE H NOWICKI MJ SUCCAR M KLEINMAN SH DIETRICH SL LUSHER JM SCHIFF ER LIAN ECY ALEDORT LM HILGARTNER MW STEVENS CD TAYLOR PE KOERPER MA BUSCH MP LEWIS BH GJERSET GF HOLLINGSWORTH CG NEMO GJ HOAK J ALTER HJ DALESSIO DJ GRADY GF HOLLAND PV ROSE NR SEEFF LB WITTES J

Gf. Gjerset et al., EFFECT OF LOW-PURITY AND INTERMEDIATE-PURITY CLOTTING FASTER THERAPY ON PROGRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN CONGENITALCLOTTING DISORDERS, Blood, 84(5), 1994, pp. 1666-1671

27

Hematology

Blood → ACNP

00064971

84

5

1994

1666 - 1671

ISI

0006-4971(1994)84:5<1666:EOLAIC>2.0.ZU;2-A